# Desloratadine as Adjunct Therapy for Rheumatoid Arthritis

> **NCT07632872** · PHASE2 · RECRUITING · sponsor: **Horus University** · enrollment: 60 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Desloratadine 5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07632872
- **Lead sponsor:** Horus University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-23
- **Primary completion:** 2026-11
- **Final completion:** 2027-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632872, "Desloratadine as Adjunct Therapy for Rheumatoid Arthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*